CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Income Statement [Abstract]
Revenues	$ 655,341	$ 382,264	$ 1,717,406	$ 1,380,787
Cost of Goods Sold	496,580	371,941	1,348,834	1,119,850
Gross Profit	158,761	10,323	368,572	260,937
Research and Development Expenses, net	159,472	198,608	533,424	498,842
Selling, General and Administrative Expenses	350,180	309,913	900,060	837,987
Gain on Sale of Assets	(897)	(7,308)	(4,599)	(9,457)
Total Operating Expenses	508,755	501,213	1,428,885	1,327,372
Operating Loss	(349,994)	(490,890)	(1,060,313)	(1,066,435)
Gain on Sale of Patents				2,276,286
Non-cash Provision for Claims for Liquidated Damages			(629,000)
Other Income		1	76,149	534
Interest Expense		(1,250)	(1,408)	(28,958)
Net Income (Loss)	$ (349,994)	$ (492,139)	$ (1,614,572)	$ 1,181,427
Income (Loss) Per Share:
Basic	$ (0.08)	$ (0.40)	$ (0.50)	$ 1.04
Diluted	$ (0.08)	$ (0.40)	$ (0.50)	$ 0.97
Weighted Average Common Shares Outstanding:
Basic	4,279,467	1,245,339	3,211,274	1,135,432
Diluted	4,279,467	1,245,339	3,211,274	1,243,527